338 related articles for article (PubMed ID: 36704327)
1. What is the role of lipids in prion conversion and disease?
Alves Conceição C; Assis de Lemos G; Barros CA; Vieira TCRG
Front Mol Neurosci; 2022; 15():1032541. PubMed ID: 36704327
[TBL] [Abstract][Full Text] [Related]
2. Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions.
Poggiolini I; Saverioni D; Parchi P
Int J Cell Biol; 2013; 2013():910314. PubMed ID: 24454379
[TBL] [Abstract][Full Text] [Related]
3. Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets.
Thellung S; Corsaro A; Dellacasagrande I; Nizzari M; Zambito M; Florio T
Front Neurosci; 2022; 16():966019. PubMed ID: 36148145
[TBL] [Abstract][Full Text] [Related]
4. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
[TBL] [Abstract][Full Text] [Related]
5. Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.
Toni M; Massimino ML; De Mario A; Angiulli E; Spisni E
Front Neurosci; 2017; 11():3. PubMed ID: 28154522
[TBL] [Abstract][Full Text] [Related]
6. Prion protein self-interaction in prion disease therapy approaches.
Rigter A; Priem J; Langeveld JP; Bossers A
Vet Q; 2011 Sep; 31(3):115-28. PubMed ID: 22029882
[TBL] [Abstract][Full Text] [Related]
7.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
8. Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts.
Matamoros-Angles A; Mohammadi B; Song F; Shafiq M; Brenna S; Puig B; Glatzel M; Altmeppen HC
Neural Regen Res; 2023 Sep; 18(9):1869-1875. PubMed ID: 36926701
[TBL] [Abstract][Full Text] [Related]
9. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
[TBL] [Abstract][Full Text] [Related]
10. Dimerization of the cellular prion protein inhibits propagation of scrapie prions.
Engelke AD; Gonsberg A; Thapa S; Jung S; Ulbrich S; Seidel R; Basu S; Multhaup G; Baier M; Engelhard M; Schätzl HM; Winklhofer KF; Tatzelt J
J Biol Chem; 2018 May; 293(21):8020-8031. PubMed ID: 29636413
[TBL] [Abstract][Full Text] [Related]
11. Animal models for prion-like diseases.
Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
[TBL] [Abstract][Full Text] [Related]
12. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
13. Preparation of lyophilized recombinant prion protein for TSE diagnosis by RT-QuIC.
Hwang S; Tatum T; Lebepe-Mazur S; Nicholson EM
BMC Res Notes; 2018 Dec; 11(1):895. PubMed ID: 30547851
[TBL] [Abstract][Full Text] [Related]
14. Generating Bona Fide Mammalian Prions with Internal Deletions.
Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
[TBL] [Abstract][Full Text] [Related]
15. A Promising Antiprion Trimethoxychalcone Binds to the Globular Domain of the Cellular Prion Protein and Changes Its Cellular Location.
Ferreira NC; Ascari LM; Hughson AG; Cavalheiro GR; Góes CF; Fernandes PN; Hollister JR; da Conceição RA; Silva DS; Souza AMT; Barbosa MLC; Lara FA; Martins RAP; Caughey B; Cordeiro Y
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133563
[TBL] [Abstract][Full Text] [Related]
16. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
17. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
18. Review: membrane-associated misfolded protein propagation in natural transmissible spongiform encephalopathies (TSEs), synthetic prion diseases and Alzheimer's disease.
Jeffrey M
Neuropathol Appl Neurobiol; 2013 Apr; 39(3):196-216. PubMed ID: 23171056
[TBL] [Abstract][Full Text] [Related]
19. Neuropathology of Animal Prion Diseases.
Orge L; Lima C; Machado C; Tavares P; Mendonça P; Carvalho P; Silva J; Pinto ML; Bastos E; Pereira JC; Gonçalves-Anjo N; Gama A; Esteves A; Alves A; Matos AC; Seixas F; Silva F; Pires I; Figueira L; Vieira-Pinto M; Sargo R; Pires MDA
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801117
[TBL] [Abstract][Full Text] [Related]
20. From prion diseases to prion-like propagation mechanisms of neurodegenerative diseases.
Acquatella-Tran Van Ba I; Imberdis T; Perrier V
Int J Cell Biol; 2013; 2013():975832. PubMed ID: 24222767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
